Amrize Ltd
AMRZ · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $3,675,000 | $3,220,000 | $2,081,000 | $2,849,000 |
| % Growth | 14.1% | 54.7% | -27% | – |
| Cost of Goods Sold | $2,589,000 | $2,254,000 | $1,859,000 | $2,072,000 |
| Gross Profit | $1,086,000 | $966,000 | $222,000 | $777,000 |
| % Margin | 29.6% | 30% | 10.7% | 27.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $312,000 | $299,000 | $244,000 | $280,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$2,000 | -$1,000 | -$22,000 |
| Operating Expenses | $312,000 | $297,000 | $243,000 | $258,000 |
| Operating Income | $774,000 | $669,000 | -$21,000 | $519,000 |
| % Margin | 21.1% | 20.8% | -1% | 18.2% |
| Other Income/Exp. Net | -$81,000 | -$119,000 | -$70,000 | $71,000 |
| Pre-Tax Income | $693,000 | $550,000 | -$91,000 | $590,000 |
| Tax Expense | $150,000 | $122,000 | -$36,000 | $130,000 |
| Net Income | $545,000 | $429,000 | -$55,000 | $459,000 |
| % Margin | 14.8% | 13.3% | -2.6% | 16.1% |
| EPS | 0.99 | 0.78 | -0.1 | 0.83 |
| % Growth | 26.9% | 883.9% | -112% | – |
| EPS Diluted | 0.99 | 0.78 | -0.1 | 0.83 |
| Weighted Avg Shares Out | 553,100 | 553,100 | 552,700 | 553,300 |
| Weighted Avg Shares Out Dil | 553,900 | 553,100 | 552,700 | 553,300 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $89,000 | $121,000 | $71,000 | -$113,000 |
| Depreciation & Amortization | $231,000 | $221,000 | $218,000 | $225,000 |
| EBITDA | $1,013,000 | $891,000 | $198,000 | $696,000 |
| % Margin | 27.6% | 27.7% | 9.5% | 24.4% |